A marijuana-regulation bill that was defeated on the Assembly floor in May has returned, revived through a gut-and-amend tactic in the final week of the Legislature’s session.
AB 604 by Assemblyman Tom Ammiano, D-San Francisco, which used to deal with eyewitness identifications in criminal investigations, is now the vehicle for Ammiano’s Medical Cannabis Regulation and Control Act, formerly AB 473. It’s coauthored by state Senate President Pro Tem Darrell Steinberg, D-Sacramento, and state Sen. Mark Leno, D-San Francisco.
The bill would require the state Department of Alcoholic Beverage Control to set up a division to monitor production, transportation and sales of medical marijuana, and would grandfather in medical marijuana businesses already operating legally under city or county laws.
“Not only are patients in California barraged by virtually daily closures of dispensaries due to aggressive attacks by the Justice Department, but the patchwork system of local bans and regulations in the state leaves hundreds of thousands of patients without safe access to medical marijuana,” said Don Duncan, California director of Americans for Safe Access. “It’s time for state legislators to roll up their sleeves and finish the job of implementing California’s medical marijuana law.”
Duncan’s group would prefer that medical marijuana be regulated by the Department of Public Health, but said it’s more important to put some sort of state regulatory structure in place so that cities and counties can’t keep imposing bans. ASA and the Sacramento chapter of the National Organization for the Reform of Marijuana Laws are staging a lobbying blitz today to build support for the legislation.
California representatives of Law Enforcement Against Prohibition support the bill, too.
“While law enforcement special interest groups have derailed bills like this before, this is something police on the ground want,” retired lieutenant commander Diane Goldstein said in a news release. “Just like anyone else, they try to do their jobs as professionally and effectively as possible. But right now, the lack of clear regulations on the medical marijuana industry means they can’t do that because they don’t know what’s legal and what isn’t.”